Company Filing History:
Years Active: 2018
Title: Jarno Robin: Innovator in Protein Production
Introduction
Jarno Robin is a notable inventor based in Skovlunde, Denmark. He has made significant contributions to the field of biotechnology, particularly in the production of haemostasis proteins. His innovative approach has the potential to impact various medical applications.
Latest Patents
Jarno Robin holds a patent for a process for protein production. This invention relates to a method for producing a haemostasis protein through continuous perfusion culturing of a cell culture in suspension. The cell culture expresses the haemostasis protein into the culture suspension, which flows across a filter module. This filter module has a mesh size ranging from 0.1 to 2.9 µm, allowing the haemostasis protein to pass through while maintaining the integrity of the cell culture. The flow across the filter module is characterized by an alternating tangential flow. Additionally, the invention encompasses the protein produced by this innovative process. He has 1 patent to his name.
Career Highlights
Jarno Robin is currently associated with Novo Nordisk Healthcare AG, a leading company in the healthcare sector. His work at Novo Nordisk focuses on advancing biotechnological processes that can enhance protein production efficiency.
Collaborations
Due to space constraints, the collaborations section has been omitted.
Conclusion
Jarno Robin's contributions to protein production through innovative processes highlight his role as a key inventor in the biotechnology field. His work has the potential to lead to significant advancements in medical treatments and therapies.